Literature DB >> 9143388

Lung involvement in neuroblastoma: incidence and characteristics.

F Cowie1, R Corbett, C R Pinkerton.   

Abstract

The presence of lung metastases in neuroblastoma often leads to doubt about the diagnosis due to rarity of disease at this site. To determine more precisely the incidence and nature of pulmonary disease in neuroblastoma the data base of the European Neuroblastoma Study Group (ENSG) was examined. Information was obtained about 35/746 stage IV patients (and 1 patient who was registered as having stage II disease) documented to have pulmonary disease at presentation. Of these 5 were registered with pleural effusions, 18 pleural infiltrations, and 13 intrapulmonary lesions. Review of these cases, however, suggested that only 9 patients (1.2%; 95% exact confidence interval 0.42-1.99%, binomial distribution) had disease consistent with secondary neuroblastoma in lung or pleura. There was no correlation with clinical features, age, sex, or other disease sites, and outcome was uniformly poor.

Entities:  

Mesh:

Year:  1997        PMID: 9143388     DOI: 10.1002/(sici)1096-911x(199706)28:6<429::aid-mpo7>3.0.co;2-i

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  12 in total

1.  Neuroblastoma with primary pleural involvement: an unusual presentation.

Authors:  Matthew Tay; Jeevesh Kapur
Journal:  Pediatr Radiol       Date:  2010-11-16

2.  Lung-residing metastatic and dormant neuroblastoma cells.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tzipi Meshel; Ido Nevo; Tobias Bäuerle; Ilana Yron; Isaac P Witz
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

3.  The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

Authors:  Tom Monclair; Garrett M Brodeur; Peter F Ambros; Hervé J Brisse; Giovanni Cecchetto; Keith Holmes; Michio Kaneko; Wendy B London; Katherine K Matthay; Jed G Nuchtern; Dietrich von Schweinitz; Thorsten Simon; Susan L Cohn; Andrew D J Pearson
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

4.  Generation and characterization of novel local and metastatic human neuroblastoma variants.

Authors:  Ido Nevo; Orit Sagi-Assif; Liat Edry Botzer; Dana Amar; Shelly Maman; Naam Kariv; Leonor E Leider-Trejo; Larissa Savelyeva; Manfred Schwab; Ilana Yron; Isaac P Witz
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 5.  Surgical treatment of pulmonary metastases in pediatric solid tumors.

Authors:  Todd E Heaton; Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2016-09-03       Impact factor: 2.754

6.  Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project.

Authors:  Steven G Dubois; Wendy B London; Yang Zhang; Katherine K Matthay; Tom Monclair; Peter F Ambros; Susan L Cohn; Andrew Pearson; Lisa Diller
Journal:  Pediatr Blood Cancer       Date:  2008-11       Impact factor: 3.167

7.  Role of positron emission tomography-computed tomography in staging and early chemotherapy response evaluation in children with neuroblastoma.

Authors:  Madhavi Chawla; Rakesh Kumar; Sandeep Agarwala; Sameer Bakhshi; Devendra Kumar Gupta; Arun Malhotra
Journal:  Indian J Nucl Med       Date:  2010-10

8.  The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.

Authors:  Annick Mühlethaler-Mottet; Julie Liberman; Kelly Ascenção; Marjorie Flahaut; Katia Balmas Bourloud; Pu Yan; Nicolas Jauquier; Nicole Gross; Jean-Marc Joseph
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

9.  Pediatric thoracic mass lesions: Beyond the common.

Authors:  Gunes Orman; Prakash Masand; John Hicks; Thierry A G M Huisman; R Paul Guillerman
Journal:  Eur J Radiol Open       Date:  2020-06-11

Review 10.  Cancer Cell Dormancy in Metastasis.

Authors:  Matthew A Summers; Michelle M McDonald; Peter I Croucher
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.